ArticlePloS one2020

Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-β, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumab.

C L Kemmerer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.